{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T20:34:11Z","timestamp":1771014851875,"version":"3.50.1"},"reference-count":17,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1016\/j.clinthera.2010.10.005","type":"journal-article","created":{"date-parts":[[2010,11,22]],"date-time":"2010-11-22T09:11:28Z","timestamp":1290417088000},"page":"1911-1916","source":"Crossref","is-referenced-by-count":12,"title":["Modulation of CD20 antigen expression after rituximab treatment: A retrospective study in patients with chronic lymphocytic leukemia"],"prefix":"10.1016","volume":"32","author":[{"given":"Fiorella","family":"D\u2019Auria","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Guariglia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oreste","family":"Villani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanna","family":"Mansueto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vitina","family":"Grieco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonia","family":"Zonno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriella","family":"Bianchino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigina","family":"Di Giovannantonio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia","family":"Vita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pellegrino","family":"Musto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2010.10.005_bib1","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.4049\/jimmunol.125.4.1678","article-title":"Characterization of a human B lymphocyte-specific antigen","volume":"125","author":"Stashenko","year":"1980","journal-title":"J Immunol"},{"key":"10.1016\/j.clinthera.2010.10.005_bib2","doi-asserted-by":"crossref","first-page":"3941","DOI":"10.1182\/blood-2007-11-120535","article-title":"Flow cytometric immunophenotyping for hematologic neoplasms","volume":"111","author":"Craig","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.clinthera.2010.10.005_bib3","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1080\/10428190802090805","article-title":"How have outcomes for patients with follicular lymphoma changed with the addition of monoclonal antibodies?","volume":"49","author":"Illidge","year":"2008","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clinthera.2010.10.005_bib4","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1586\/era.09.30","article-title":"Rituximab and chemotherapy in diffuse large B-cell lymphoma","volume":"9","author":"Sonet","year":"2009","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.clinthera.2010.10.005_bib5","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1182\/blood-2008-02-140582","article-title":"Long-term results of the fludarabine, cyclophosphamide, and rituximab regimen as initial therapy of chronic lymphocytic leukemia","volume":"112","author":"Tam","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.clinthera.2010.10.005_bib6","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1053\/j.seminhematol.2008.02.001","article-title":"Antibody therapy for chronic lymphocytic leukemia","volume":"45","author":"Christian","year":"2008","journal-title":"Semin Hematol"},{"key":"10.1016\/j.clinthera.2010.10.005_bib7","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1080\/1042819021000040044","article-title":"Recurrent B-cell neoplasms after rituximab therapy: An immunophenotypic and genotypic study","volume":"43","author":"Chu","year":"2002","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clinthera.2010.10.005_bib8","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1034\/j.1600-0609.2003.00007.x","article-title":"Loss of CD20 expression in relapsed lymphomas after rituximab therapy","volume":"70","author":"Haidar","year":"2003","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.clinthera.2010.10.005_bib9","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1177\/039463200601900218","article-title":"Bone marrow histopathological and molecular changes of small B-cell lymphomas after rituximab therapy: Comparison with clinical response and patients outcome","volume":"19","author":"Goteri","year":"2006","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1016\/j.clinthera.2010.10.005_bib10","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/01.pai.0000145130.02931.74","article-title":"Immunophenotypic changes and clinical outcome in B-cell lymphomas treated with rituximab","volume":"14","author":"Seliem","year":"2006","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.clinthera.2010.10.005_bib11","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1349-7006.2008.01005.x","article-title":"Histological and immunophenotypic changes in 59 cases of B-cell non-Hodgkin's lymphoma after rituximab therapy","volume":"100","author":"Maeshima","year":"2009","journal-title":"Cancer Sci"},{"key":"10.1016\/j.clinthera.2010.10.005_bib12","doi-asserted-by":"crossref","first-page":"4885","DOI":"10.1182\/blood-2008-08-175208","article-title":"Down-regulation of CD20 expression in B-cell lymphoma cells after treatment with rituximab-containing combination chemotherapies: Its prevalence and clinical significance","volume":"113","author":"Hiraga","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.clinthera.2010.10.005_bib13","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/cncr.20773","article-title":"Richter syndrome: Biology, incidence, and therapeutic strategies","volume":"103","author":"Tsimberidou","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.clinthera.2010.10.005_bib14","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3109\/10428190903515192","article-title":"A systematic review on Richter syndrome: What is the published evidence?","volume":"51","author":"Molica","year":"2010","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clinthera.2010.10.005_bib15","doi-asserted-by":"crossref","first-page":"3514","DOI":"10.1182\/blood-2003-01-0055","article-title":"Transient down-modulation of CD20 by rituximab in patients with chronic lymphocytic leukemia","volume":"102","author":"Jilani","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.clinthera.2010.10.005_bib16","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.leukres.2005.09.008","article-title":"Analysis of changes in CD20, CD55, and CD59 expression on established rituximab-resistant B-lymphoma cell lines","volume":"30","author":"Takei","year":"2006","journal-title":"Leuk Res"},{"key":"10.1016\/j.clinthera.2010.10.005_bib17","doi-asserted-by":"crossref","first-page":"3280","DOI":"10.4049\/jimmunol.172.5.3280","article-title":"Rituximab infusion promotes rapid complement depletion and acute CD20 loss in chronic lymphocytic leukemia","volume":"172","author":"Kennedy","year":"2004","journal-title":"J Immunol"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291810003449?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291810003449?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,4]],"date-time":"2023-06-04T07:51:34Z","timestamp":1685865094000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291810003449"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":17,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["S0149291810003449"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2010.10.005","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]}}}